Epstein Secrets

er, Cornwell) reports Mnuchin "said talks with...Pelosi made progress" but adds that Pelosi "avoided use of the term 'progress." fl Rnll Cal( (9/30, Lerman, 154K) describes Pelosi's statement as "more circumspect." Bloomberg (9/30, Wasson, House, 4.73M) EFTA00135741 reports Pelosi's statement "said s

ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

r, Cornwell) reports Mnuchin "said talks with...Pelosi made progress" but adds that Pelosi "avoided use of the term 'progress." CQ Roll Call (9/30, Lerman, 154K) describes Pelosi's statement as "more circumspect." Bloomberg (9/30, Wasson, House, 4.73M) reports Pelosi's statement "said she and Mnuchin

nsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

r, Cornwell) reports Mnuchin "said talks with...Pelosi made progress" but adds that Pelosi "avoided use of the term 'progress:" CQ Roll Call (9/30, Lerman, 154K) describes Pelosi's statement as "more circumspect." Bloomberg (9/30, Wasson, House, 4.73M) reports Pelosi's statement "said she and Mnuchin

ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v